CDH1 and neoplasm: Integrin α5 up-regulation was identified as the molecular mechanism by which E-cadherin loss promotes tumor progression [23] and ERBB2-mediated transcriptional up-regulation of the α5β1 promotes tumor cell survival under adverse conditions [24].